This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
B&G Foods (BGS) Down 15% in 3 Months: High Costs a Key Reason
by Zacks Equity Research
B&G Foods (BGS) expects to keep seeing significant cost inflation for inputs, such as ingredients, packaging and transportation, in fiscal 2022.
B&G Foods' (BGS) New Business Unit Structure to Boost Growth
by Zacks Equity Research
B&G Foods (BGS) is forming four business units, Spices & Seasonings, Meals, Frozen & Vegetables and Specialty.
Exxon Mobil and B&G Foods have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Exxon Mobil and B&G Foods are part of Zacks Bull and Bear of the Day article.
B&G Foods (BGS) Troubled by Cost Inflation, Supply-Chain Woes
by Zacks Equity Research
B&G Foods (BGS) has been encountering industry-wide inflation in input costs and supply-chain bottlenecks. Management cuts its adjusted EBITDA and EPS forecast due to cost inflation.
Bear of the Day: B&G Foods (BGS)
by Tracey Ryniec
Cost inflation is hitting the maker of Green Giant.
New Strong Sell Stocks for May 9th
by Zacks Equity Research
AXAHY, BGS, and AAGIY have been added to the Zacks Rank #5 (Strong Sell) List on May 9, 2022.
B&G Foods (BGS) Q1 Earnings Miss Estimates, EPS View Lowered
by Zacks Equity Research
B&G Foods' (BGS) first-quarter fiscal 2022 results reflect gains from high demand and pricing actions, whereas the escalated input cost inflation hurts margins.
B&G Foods (BGS) Q1 Earnings Lag Estimates
by Zacks Equity Research
B&G Foods (BGS) delivered earnings and revenue surprises of -12.82% and 4.30%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
The J.M. Smucker (SJM) Gains on Demand Amid Cost Hurdles
by Zacks Equity Research
The J.M. Smucker (SJM) has been gaining on the revival in away from home demand and its focus on core priorities, while cost headwinds have been a concern.
Medifast (MED) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Medifast (MED) delivered earnings and revenue surprises of 0.84% and 0.58%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
B&G Foods' (BGS) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
B&G Foods' (BGS) first-quarter 2022 performance will likely reflect gains from higher demand and strategic buyouts. However, escalated cost inflation is a concern.
Earnings Preview: B&G Foods (BGS) Q1 Earnings Expected to Decline
by Zacks Equity Research
B&G Foods (BGS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
B&G Foods (BGS) Down 8.3% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
B&G Foods (BGS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
B&G Foods (BGS) Stock Declines 13% YTD on Cost Inflation
by Vrishali Bagree
B&G Foods (BGS) is encountering escalated cost concerns. Management expects to keep seeing significant cost inflation for inputs, such as ingredients, packaging and transportation.
Mondelez (MDLZ) Well Poised on Brand Strength Amid Cost Woes
by Zacks Equity Research
Mondelez International (MDLZ) has been benefiting from its prudent acquisitions. Also, its pricing and saving strategies are helping amid an inflationary cost environment.
New Strong Sell Stocks for March 14th
by Zacks Equity Research
AVYA, BGS, and CMMB have been added to the Zacks Rank #5 (Strong Sell) List on March 14, 2022.
B&G Foods (BGS) Q4 Earnings Lag Estimates: Input Costs High
by Zacks Equity Research
B&G Foods' (BGS) fourth-quarter fiscal 2021 results reflect year-over-year growth in earnings and sales. Gains from Crisco's buyout and high demand aid the company amid high input costs and supply-chain challenges.
B&G Foods (BGS) Q4 Earnings and Revenues Lag Estimates
by Zacks Equity Research
B&G Foods (BGS) delivered earnings and revenue surprises of -7.14% and 2.33%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Darling Ingredients (DAR) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Darling (DAR) delivered earnings and revenue surprises of 14.63% and 11.03%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
B&G Foods (BGS) to Post Q4 Earnings: What's in the Offing?
by Zacks Equity Research
B&G Foods' (BGS) fourth-quarter 2021 results are likely to reflect gains from high demand and prudent buyouts, while cost inflation is a concerning factor.
New Strong Sell Stocks for February 3rd
by Zacks Equity Research
AGNC, APAM, and BGS have been added to the Zacks Rank #5 (Strong Sell) List on February 3, 2022
Is WisdomTree U.S. SmallCap Dividend ETF (DES) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for DES
Medifast (MED) Looks Great on OPTAVIA, Strategic Investments
by Zacks Equity Research
Medifast (MED) has been benefiting from the strength of its OPTAVIA lifestyle solution and coaching support system, as well as efficient technological investments.
Should WisdomTree U.S. SmallCap Dividend ETF (DES) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for DES
Prudent Acquisitions Aid B&G Foods (BGS), High Costs Persist
by Zacks Equity Research
B&G Foods (BGS) is actively pursuing strategic acquisitions to boost growth. However, input cost inflation and higher SG&A expenses are a concern.